Where does Egg Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Egg Medical, Inc. ranks #24,254 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Egg Medical, Inc. hold?

Egg Medical, Inc. holds 11 US utility patents granted between 2018 and 2024, spanning 6 technology areas.

What is Egg Medical, Inc.'s Innovation Score?

Egg Medical, Inc. has an Innovation Score of 43.9 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Egg Medical, Inc. focus on?

Egg Medical, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 11 patents, ranking #1,592 of 7,127 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Egg Medical, Inc.'s patent grant rate increasing or decreasing?

Egg Medical, Inc.'s recent grant velocity is +350% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Egg Medical, Inc.'s patents?

Egg Medical, Inc.'s patents average 18.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Egg Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Egg Medical, Inc.

USPTO PatentsView assignee record - 11 granted patents across 6 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Egg ranks #24,254 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 6 technology areas.

#24,254
of 49,997 US assignees by volume: Top 27%
by Innovation Score (43.9/100): 18.6
avg claims per patent: +350%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24254 · US Corporation #24,254 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,254/49,997
PHOTO-FINISH Ecodyst
CPC-NARROW A61B · 6 areas
INNOV-PAR 43.9/100
CLAIMS-RICH 18.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +350% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ecodyst, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Egg’s 43.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (20%) Velocity 15.6 pts (35%) Breadth 8.7 pts (20%) Claim depth 11.1 pts (25%)

Qualcomm Incorporated · highest

85
Egg Medical · this assignee

44
3D Lighting… · lowest

7

What this shows Egg's Innovation Score is 43.9/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Egg?

Each dot is one of Egg’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Egg’s own 18.6 claims/patent is ABOVE the 17.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Egg vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Egg's grants concentrate

Egg Medical, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2018. By volume, Egg sits between Ecodyst, Inc. and Elekta AB.

Egg's three-year grant acceleration

Egg Medical, Inc. shows 7 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ecodyst

11
Ecolean AB

11
Ecolibrium Solar

11
Edeniq

11
Egress Software IP

11
Electratherm

11
Electric Torque M…

11
Elekta AB

11
Egg Medical ◀

11

What this shows Egg holds 11 patents at rank #24,275, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Egg

By rank, the assignees closest to #24,275 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Egg's primary technology class.

Egg's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Egg Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	9.1%
2019	1	9.1%
2021	2	18.2%
2022	2	18.2%
2023	1	9.1%
2024	4	36.4%

Which technologies does Egg Medical, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 11

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 9

G21F - Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation OR Particle BOMBARDMENT; Treating Radioactively Contaminated MATERIAL; Decontamination Arrangements Therefor 7

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Egg Medical, Inc.'s patent record in context - here's where to go next.

Egg Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #24,254 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Egg Medical, Inc. against Ecodyst, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.